(Q43662778)

25 November 2017

0 references

Tamoxifen and contralateral breast cancer: the other side (English)

1 reference

25 November 2017

1 reference

1

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

Journal of the National Cancer Institute

25 November 2017

published in

1 reference

25 November 2017

volume

93

1 reference

25 November 2017

issue

13

1 reference

25 November 2017

page(s)

963-965

1 reference

The Molecular Pharmacology of SERMs

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.13.963

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.13.963

Tamoxifen therapy for primary breast cancer and risk of contralateral breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.13.963

Reliability of immunohistochemical demonstration of oestrogen receptors in routine practice: interlaboratory variance in the sensitivity of detection and evaluation of scoring systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.13.963

Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.13.963

Measurement of steroid hormone receptors in breast cancer patients on tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.13.963

Oestrogen receptor: a stable phenotype in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.13.963

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.13.963

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.13.963

The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.13.963

21 January 2018

Identifiers

DOI

10.1093/JNCI/93.13.963

1 reference

25 November 2017

1 reference